• Insurance Quotes
  • Contact
  • Privacy Policy
  • Terms & Conditions
Wednesday, May 13, 2026
Insure Monkey
844-226-8876
  • Home
  • Low Cost Health Insurance
  • News
    • Health Insurance
    • Insurance for Business
    • Health Care
    • Medicare
    • Casualty Insurance
    • Insurance Education
    • Life Insurance
  • Contact
  • Home
  • Low Cost Health Insurance
  • News
    • Health Insurance
    • Insurance for Business
    • Health Care
    • Medicare
    • Casualty Insurance
    • Insurance Education
    • Life Insurance
  • Contact
No Result
View All Result
Morning News
No Result
View All Result
Home Health Insurance

New Flu Vax? FDA Says No Thanks

February 16, 2026
in Health Insurance
0
The Government Is Open – KFF Health News
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

READ ALSO

Abortion Pill Politics – KFF Health News

In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.

The Host

Julie Rovner
KFF Well being Information


@jrovner

@julierovner.bsky.social

Learn Julie’s tales.

Julie Rovner is chief Washington correspondent and host of KFF Well being Information’ weekly well being coverage information podcast, “What the Well being?” A famous knowledgeable on well being coverage points, Julie is the writer of the critically praised reference e book “Well being Care Politics and Coverage A to Z,” now in its third version.

The Meals and Drug Administration is again within the headlines, with a political appointee overruling company scientists to reject an software from the drugmaker Moderna for a brand new flu vaccine, and FDA Commissioner Marty Makary persevering with to take criticism from anti-abortion Republicans within the Senate for alleged delays reviewing the protection of the abortion capsule mifepristone.

In the meantime, in a not possible pairing, Sen. Elizabeth Warren, the Massachusetts Democrat, and Sen. Josh Hawley, the conservative Republican from Missouri, are co-sponsoring laws geared toward breaking apart the “vertical integration” of well being care — when a single firm owns well being insurers, drug middlemen, and clinician practices.

This week’s panelists are Julie Rovner of KFF Well being Information, Jackie Fortiér of KFF Well being Information, Lizzy Lawrence of Stat, and Alice Miranda Ollstein of Politico.

Panelists

Jackie Fortiér
KFF Well being Information

Learn Jackie’s tales.

Lizzy Lawrence
STAT Information


@LizzyLaw_

@lizzylawrence.bsky.social

Prepared Lizzy’s tales.

Alice Miranda Ollstein
Politico


@AliceOllstein

@alicemiranda.bsky.social

Learn Alice’s tales.

Among the many takeaways from this week’s episode:

  • A high FDA official overruled company employees in refusing to contemplate Moderna’s software for a brand new flu vaccine. The rejection, which Moderna is difficult, comes after the corporate consulted with the company beneath President Joe Biden on find out how to develop the scientific trial for the vaccine after which spent appreciable money and time. Clear, constant federal steering is vital to sustaining the drug growth ecosystem, and the choice stands as a warning to different corporations creating new therapies.
  • With measles circumstances rising and belief in federal vaccine suggestions falling, the Vaccine Integrity Mission, primarily based on the College of Minnesota’s Heart for Infectious Illness Analysis & Coverage, and the American Medical Affiliation are launching their very own vaccine overview course of — a parallel vaccine suggestion challenge providing a substitute for what are seen as ideologically pushed federal suggestions.
  • President Donald Trump unveiled the brand new TrumpRx web site, billed as serving to folks get monetary savings on pharmaceuticals. However the web site’s choices are restricted and supply restricted advantages: It serves solely these attempting to purchase medicine with out insurance coverage protection, and a few of the largest financial savings are on standard weight problems medicine moderately than different generally wanted therapies. Nonetheless, it provides Trump an opportunity to stamp his title on an effort to decrease drug costs.
  • And extra reporting is illuminating the health-related uncomfortable side effects of Trump’s immigration crackdown, together with infectious illness outbreaks at detention facilities. Whereas at the very least a few of the issues will not be new to immigration enforcement, the massive numbers of individuals being detained are intensifying the issues.

Plus, for “further credit score” the panelists recommend well being coverage tales they learn this week that they suppose you need to learn, too: 

Julie Rovner: ProPublica’s “The Youngsters of Dilley,” by Mica Rosenberg.  

Alice Miranda Ollstein: Politico’s “Why Washington’s All-In on Sensible Rings,” by Amanda Chu.  

Lizzy Lawrence: KFF Well being Information’ “US Most cancers Institute Learning Ivermectin’s ‘Potential To Kill Most cancers Cells,’” by Rachana Pradhan.  

Jackie Fortiér: Stat’s “The New Childhood Vaccine Pointers Have a Paid Depart Drawback,” by Ariana Hendrix.  

Additionally talked about on this week’s episode:

Click on to open the transcript

Transcript: New Flu Vax? FDA Says No Thanks

[Editor’s note: This transcript was generated using both transcription software and a human’s light touch. It has been edited for style and clarity.] 

Julie Rovner: Howdy from KFF Well being Information and WAMU public radio in Washington, D.C. Welcome to What the Well being? I’m Julie Rovner, chief Washington correspondent for KFF Well being Information, and I’m joined by a few of the perfect and smartest well being reporters protecting Washington. We’re taping this week on Thursday, Feb. 12, at 10 a.m. As all the time, information occurs quick, and issues may need modified by the point you hear this. So, right here we go. 

Right this moment, we are joined by way of videoconference by Alice Miranda Ollstein of Politico. 

Alice Miranda Ollstein: Howdy. 

Rovner: Lizzy Lawrence of Stat Information. 

Lizzy Lawrence: Hello.  

Rovner: And up early to affix us from California, my KFF Well being Information colleague Jackie Fortiér. Welcome, Jackie.  

Jackie Fortiér: Hey, everybody. 

Rovner: No interview this week, however loads of information. So let’s soar proper in. We’ll begin this week on the Meals and Drug Administration, the place issues are — why don’t we name it — newsmaking. The most important FDA story that broke this week was controversial vaccine chief Vinay Prasad outright rejecting an software for a brand new flu vaccine from Moderna, maker of the mRNA covid vaccine that so many anti-vaxxers have criticized. Lizzy, you broke this story. Congratulations. What occurred precisely? And why is that this such a giant deal past the flu vaccine? 

Lawrence: This is a giant deal as a result of to refuse to file is a reasonably uncommon incidence usually, as a result of usually the FDA and trade prefer to have agreed-upon requirements for scientific trials earlier than corporations embark on them and pour tens of millions of {dollars} into them. In order that was shocking. After which— 

Rovner: And refuse to file implies that they stated that they’ve received the appliance and stated: Yeah, we’re not accepting that. We’re not going to overview this. Proper? 

Lawrence: Sure, sure. And Prasad wrote that the grounds for this was that it wasn’t an ample, managed trial. Properly, Moderna is saying that really the FDA greenlit this trial again beneath the Biden administration in 2024. They acknowledged that there was principally a management vaccine that the FDA say they would favor that Moderna use for the older inhabitants. However they stated, nevertheless, it’s acceptable should you don’t try this. 

Rovner: And I wish to be sure I perceive this. The complication right here is that that is presupposed to be a greater vaccine for older folks, however proper now there’s vaccines for older those that begin at age 65 and it is a vaccine that’s supposed to begin at age 50, proper? So it was unclear who they had been going to check it towards, whether or not it was going to be the 50-to-64s or the 65s and older. As a result of there isn’t a vaccine proper now that’s accepted for 50 and up, proper? 

Lawrence: Precisely, precisely. So it was there’s the high-dose vaccine, which is beneficial for the above-65s, however that shouldn’t be beneficial for the 50-to-64, which is a part of why Moderna didn’t use that high-dose vaccine, as a result of the inhabitants that they had been finding out was broader than this over-65s. So anyway, so yeah, so refusing to file is already uncommon, after which for there to be an overriding refuse to file, the place the, I was informed, principally, whereas there might have been people who agreed with Dr. Prasad’s evaluation, the overview group, each self-discipline, thought that it was reviewable. And the pinnacle of vaccines wrote a memo explaining why he thought it was viable, in order that the profession employees form of documented their ideas right here. It’s not clear whether or not this can be made public ever, however one would hope, with radical transparency, however we’ll see. Regardless of that, Dr. Prasad nonetheless refused to overview Moderna’s software. 

Rovner: So clearly it’s a giant deal for the flu vaccine, however it’s a giant deal past this. Moderna’s CEO was on cable information this morning, stated that, as you stated, after consulting with the FDA officers in regards to the trial, they spent a billion {dollars} on this trial. How can we anticipate corporations to spend money on new medicines like this if the FDA is principally performing on vibes? 

Lawrence: I don’t know. Yeah. And it’s attention-grabbing. It doesn’t appear to be there’s a ton of sympathy from this administration. Even again final 12 months, [FDA] Commissioner [Marty] Makary tweeted one thing — this was after they had been limiting, needed to require extra knowledge for covid vaccines for the under-65 crowd. And I believe he stated one thing like: Our aim is to not save corporations cash. That’s not one thing we — which of course that isn’t. The FDA’s aim is to advertise public well being. However it’s positively a change in tune. I believe that previously, the FDA has understood that you just’re actually solely going to get innovation if in case you have clear, constant steering and that it’s a actually worst-case state of affairs for a corporation to spend a billion {dollars} on a scientific trial after which there’s nothing to point out for it and nothing for it to profit sufferers, both. So. 

Rovner: Is that this over? What occurs now? 

Lawrence: So now Moderna has requested a gathering to problem this determination, and now there begins a form of negotiation. It may be attainable that the FDA would, in truth, would overview at least the 50-to-64 cohort, as a result of they don’t have any objections there, seemingly. However we’ll should see. On a name yesterday, a senior FDA official talked about Moderna form of coming to the company with humility and acknowledging that the FDA had beneficial this high-dose vaccine. And so I don’t know. I believe corporations are positively — it’s a lesson that they’re, particularly if you’re within the vaccine house, you should tread very fastidiously. 

See also  Exclusive: Senator Urges Biden Administration To Thwart Fraudulent Obamacare Enrollments

Rovner: Yeah. And I’d suppose others within the drug house, too. It’s not simply — that’s the purpose of this — it’s not simply vaccines. Alice, you needed to say one thing. 

Ollstein: Oh, yeah. Not solely the financial funding, which we’ve touched on a bunch, however corporations spend years. So it’s the time funding as properly. And why would you dedicate years of effort to one thing that you’re unsure if a political appointee goes to swoop in and override profession scientific officers’ evaluation, if you can’t belief the regulatory system to work as it’s all the time labored. There actually is simply a variety of danger there, and also you would possibly see folks not making these submissions on every kind of fronts. In fact, that is coming as we’ve had a actually unhealthy flu season. I’ve had folks in my life get actually sick and say it’s been actually, actually unhealthy. So the prospect of getting one thing that works higher to stop, and even simply make it milder, not coming to fruition is tough. 

Rovner: Yeah. And this 12 months, as we all know, this 12 months’s flu vaccine was not very properly matched to the strains that ended up circulating. And that’s form of the level of this Moderna vaccine, this mRNA vaccine, is that they are saying it might be a lot sooner for them to match strains to what’s going round. If it really works because the scientific trials recommend it might really be a greater flu vaccine than we’ve got now. 

Properly, in the meantime, circumstances of measles are additionally persevering with to multiply, as they do when folks aren’t vaccinated, and never simply within the locations we’ve talked about, like Texas and South Carolina, but in addition throughout us right here within the nation’s capital, apparently, on account of folks touring right here for the anti-abortion March for Life in January. There have been greater than 730 confirmed circumstances of measles within the U.S. already this 12 months. That’s 4 occasions greater than have been typical for a full 12 months, and it’s not but the center of February. But that doesn’t appear to be deterring the administration from its anti-vaccine actions. So now, the American Medical Affiliation and the College of Minnesota Vaccine Integrity Mission have introduced they’ll convene a parallel group of consultants to make vaccine suggestions, principally saying they are accomplished following the Facilities for Illness Management and Prevention. This has been brewing for some time. Proper, Lizzy? 

Lawrence: Sure. As quickly because the secretary fired all of the consultants who served on the advisory panel to the CDC on vaccines, I believe there’s been unease. And now, as you stated, there’s an lively parallel public well being institution that’s attempting to unfold credible info and supply an alternate useful resource, as a result of it’s clear that HHS [the Department of Health and Human Services] has change into compromised in the case of vaccine suggestions. And but, you’re seeing the unfold of infectious ailments proper now. 

Fortiér: Having form of this rival courtroom isn’t a surprise, as a result of they’ve refused to take part in any of the Advisory Committee on Immunization Practices conferences for months and months. I do marvel if this can possibly change a few of the tone. We do have an upcoming ACIP assembly in February. Usually we’d have a agenda out by now. Earlier than Secretary [Robert F.] Kennedy [Jr.] we’d have them weeks upfront, and we haven’t seen one but, so we’re actually not completely certain what they’re going to be speaking about. However Dr. [Mehmet] Oz did say this week that he lastly suggested folks — he’s the CMS [Centers for Medicare & Medicaid Services] director— to take the vaccine. And there’s been over 933 circumstances in simply South Carolina throughout this outbreak that began final October. And so once I discuss to folks on the bottom who’re treating people in South Carolina and have been treating them for months, and so they’ve been doing vaccine clinics and issues like that, they had been simply so fed up with Dr. Oz and the administration, as a result of they partially blame them for these varied outbreaks. And I had one in every of them inform me, like, properly, it’s like a band-aid on a bullet gap. Like, now they’re lastly encouraging folks to get vaccinated once we may have had this months in the past. 

Rovner: And, in fact, the CDC doesn’t have a director in the meanwhile, as a result of the Senate-approved director was summarily fired and/or give up, not clear which, after refusing to principally rubber-stamp the immunization panel’s suggestions that had not been made on the time. So the American Academy of Pediatrics is suing to cease this February ACIP assembly. I didn’t hear what the final determination was on that, however I do know that there’s nonetheless a variety of motion round right here. I suppose the large fear is: Who ought to the general public belief now? Is it going to be this type of grouping of medical societies led by the AMA, or the CDC, which individuals and medical doctors are used to following the recommendation of? 

Ollstein: And there’s all these state alliances forming to do the identical factor. And so I believe, yeah, the extra competing suggestions the typical particular person hears, the extra they simply type of throw their palms up and say: I don’t even know who to belief anymore. I’m not listening to any of those folks. And the belief that’s eroded within the federal authorities, that’s going to be actually exhausting to recuperate sooner or later. You can’t simply flip a change and say: OK, it’s a distinct authorities. We belief them once more. As soon as these seeds of doubt are planted in folks’s minds, it’s actually exhausting to unearth. And so, if not everlasting injury, all of that is doing at the very least very long-term injury to the thought of experience and authoritative info. 

Rovner: And science, which this administration insists it desires to comply with. Properly, turning to FDA-related “MAHA” [“Make America Healthy Again”] information, the company stated final week it might calm down enforcement of its meals additive rules to make it simpler for producers to say they’re not utilizing synthetic dyes. Now this was an enormous deal when the company introduced the phaseout of synthetic coloring. you, fancy-colored Froot Loops. Now the administration says it’s going to permit foodmakers to say they’re not utilizing synthetic colours so long as they’re not utilizing petroleum-based dyes. Apparently, pure dyes are OK. However even that’s controversial, and it seems that this entire effort actually depends on producers’ willingness to conform moderately than, you realize, precise regulation, which is form of what the FDA does for a residing. It’s a regulatory company. 

Ollstein: Properly, each time the phrase “pure” comes up, I all the time chuckle as a result of there isn’t a definition of that. And there are loads of issues which might be pure that might kill you or harm you very badly. And there are loads of issues that are synthetically manufactured which might be useful and positive for you. And so it has this veneer of security, veneer of well being with no precise substance. So my crimson flags go up at any time when I hear that phrase, and I believe everybody must be skeptical. 

Rovner: However it goes with RFK Jr.’s quest now that you need to, quote, “eat actual meals.” 

Lawrence: Proper. Yeah. I used to be going to say identical with “chemical.” I really feel like, “chemical” abortion drug, “chemical.” And it’s like, a variety of issues are chemical substances. That’s not— 

Ollstein: Yeah, like in your individual physique, naturally. 

Lawrence: Yeah. 

Ollstein: You could have chemical substances. 

Lawrence: We’re chemical substances. 

Ollstein: We’re chemical substances. 

Rovner: You guys are all too younger to recollect the Dow Chemical promoting line “Higher Residing By means of Chemistry,” which on the time, within the ’60s and ’70s, was true. There was, there — we’ve had a lot of higher residing by way of chemistry. And a few of it has turned out to be possibly not so good for us, however a variety of it has turned out to be fairly darn good for us. 

Properly, lastly, in FDA land, Commissioner Marty Makary this week met with anti-abortion senators about that ongoing overview of the abortion capsule mifepristone, which senators need the FDA to take away from the market. Alice, how’d that assembly go? 

Ollstein: Not nice for the FDA, from what I was informed. I received on the cellphone with Sen. Josh Hawley after it, and he was extraordinarily pissed off. He stated he didn’t get solutions to any of the questions he’s been sending in public letters to the FDA for months and now asking on this briefing behind closed doorways that they held on Capitol Hill this week. He stated he didn’t get solutions about what the timeline is for this overview of the abortion capsule mifepristone, what the overview consists of, whether or not it’s even begun, actually, whether or not it’s even underway. And so he’s type of concluding that this isn’t going wherever, and he desires Congress to step in and take motion. Now, Congress has tried to step in and take motion earlier than. They’ve tried to place restrictions on mifepristone within the FDA funding invoice. That didn’t go. So I don’t know if that is even believable on this setting the place Congress can’t actually go a lot of something anymore. 

However Hawley is not simply one other Republican senator. He’s very intertwined with the anti-abortion motion. His spouse is an extraordinarily outstanding anti-abortion lawyer who’s led a variety of the main circumstances attempting to limit or ban mifepristone. They based their very own anti-abortion advocacy group. And so it actually reveals that the tensions, clashes, no matter we wish to name them, between the anti-abortion motion and the Trump administration, so after backing the Trump administration for years and years, they’re actually getting fed up. And they’re fed up that even after they achieved their grand aim of overturning Roe v. Wade, there are really extra abortions occurring now than earlier than, and that’s largely by way of these tablets and other people’s capacity to get them. And so they’re getting more and more impatient with the Trump administration, who has been type of stringing them alongside and saying: Yeah, we’re engaged on it. We’re engaged on it. However they wish to see outcomes. Now, in fact, if there have been some type of restrictions imposed, that might have a giant political impact. And so a variety of Republicans are very torn about that. However not Sen. Hawley. Sen. Hawley desires to see it.  

See also  Sen. Ron Johnson Clashes With CDC, FDA Over COVID Vaccines

Rovner: That’s proper. Properly, transferring to what I name FDA-adjacent information, one of many many thorny points that FDA has been coping with is the compounding of these highly regarded and really dear weight problems medicine. When the medicine had been in scarcity, it was authorized for compounders to make their very own copies. However now the scarcity for each of the main drugs — semaglutide, made by Novo Nordisk, and tirzepatide, made by Eli Lilly — is over, and people cheaper copycats had been presupposed to be pulled from the market. So it was a little bit of a shock when the corporate Hims, a type of direct-to-consumer drug websites, introduced the disclosing of a semaglutide pill simply weeks after the primary such drug was accepted by the FDA, by Novo Nordisk. The FDA promptly referred the corporate to the Justice Division for attainable violation of federal drug legal guidelines, after which Hims stated, Oh, possibly we gained’t begin promoting the drug in any case. Oh, and Novo is suing for patent infringement. However I’d suppose that the battle over the “fats” medicine, as President [Donald] Trump likes to name them, is prone to decrease costs simply as successfully as authorities regulation would possibly. Or am I misreading that? Lizzy, this has been fairly the sideshow, if you’ll. 

Lawrence: Yeah. It would. I believe that the compounding, the FDA’s crackdown on Hims was very attention-grabbing to me as a result of I believe earlier than the commissioner had come into his function, there was some hypothesis. He had labored for a telehealth firm that prescribed compounded medicine. And there’s additionally, I believe compounders have tried to faucet into a little bit little bit of the MAHA medical freedom facet. However clearly that’s not been the case, at least on the FDA. They’re clearly very upset about this and imply enterprise, and I believe it’s tying into their crackdown on direct-to-consumer drug promoting as properly. However so far as value, yeah. I believe the offers that Trump has managed to strike with the businesses may really be decreasing value for sufferers. I believe we’ll should see. I do know there’s clearly drug pricing applications as properly that they may pursue. So, yeah, we’ll should see.  

Rovner: All proper. Properly, we’re going to take a fast break. We will probably be proper again. 

OK. We’re again. And talking of President Trump, there’s additionally drug information this week that’s not immediately associated to the FDA. That’s the official unveiling of TrumpRx, the web site the president says will decrease drug costs like nobody’s “ever seen earlier than.” That’s a direct quote, by the best way. Besides it seems that’s not fairly the case. First, these reductions are just for people who find themselves paying out-of-pocket, not these with insurance coverage, which makes them precious principally for individuals who haven’t any protection or individuals who take medicine that insurance coverage typically doesn’t cowl, like these for weight problems or infertility. But of the 43 medicine to date that are promoted on the TrumpRx web site, about half have already got cheaper generic copies out there by way of websites like GoodRx and Mark Cuban’s Price Plus Medicine. And actually, the web site simply factors folks to already current producer web sites that had been already providing these decrease costs. So what’s the level of TrumpRx? 

Lawrence: Nice query. Yeah. This administration has been very centered on, clearly, media and wins and attaching President Trump’s title to issues. So it accomplishes that aim. Possibly it does elevate consciousness for these different websites that exist already. However that’s a theme of a variety of the motion on well being care to date, has been — there’s been a variety of chaos, after which there’s additionally typically issues that they announce as like a grand, brand-new, no-one’s-ever-thought-of-it-before coverage, however then there are already, in fact, current applications or avenues for that. 

Rovner: And to be truthful, Trump has jawboned down some costs, together with some costs for the weight problems medicine, by principally dragging within the CEOs of those corporations and saying, You will decrease costs. 

Lawrence: Yeah, yeah. The dealmaking has been efficient. And I believe the query is: Will this final past his administration? Will there be a legacy there? 

Ollstein: I believe there’s additionally some hazard in overpromising, as a result of he’s on the market saying issues that don’t comport with how math works. He’s principally suggesting costs will come down so many percents that we’ll be getting paid to take medicine, as a result of that’s what greater than 100% is. And people who find themselves listening to that, voters who’re listening to that, in the event that they aren’t seeing that present up of their payments, in the event that they’re not really seeing these drastic, drastic drops that they’re being promised by the president, are they going to get upset? And is that going to influence how they vote? So sure, there was some, on the margins, enhancements, however when you’re on the market promising 600% reductions and never delivering, there’s a danger to that. 

Rovner: Jackie, you needed so as to add one thing. 

Fortiér: Properly, I used to be going to say, I believe it’s additionally complicated for lots of people, from a client perspective, as a result of you go surfing and I believe folks, they hear these enormous guarantees, like Alice is speaking about, after which they suppose that they will, essentially, purchase the medicine by way of there and instantly get them shipped, what these third events like Hims and Weight Watchers are doing a variety of with the GLP-1s. And that’s not how this works. You continue to have one other step of getting a prescription after which going to the pharmacy and utilizing these to doubtlessly get reductions and decrease costs, in the identical means that these have been out there from pharmaceutical producers and different issues like GoodRx for years. However it’s that disconnect between, even when you may get a reduction, really getting the low cost and crediting the Trump administration for that that I believe goes to be actually troublesome for a variety of voters to make that connection in the best way that the administration desires them to. 

Rovner: And this was ever the case with rebates — for different client merchandise, not simply speaking about medicine. We’ll provide you with a $15 rebate, however you should fill out 87 types and ship it to this place and get it precisely proper, do it earlier than the tip date, and we’ll ship you again $15. As a result of they depend on most individuals not having the ability or prepared to comply with all of the varied steps. So as an alternative of giving everyone the discounted value, they make you actually principally work to your low cost, which is a client factor, nevertheless it’s fairly standard in the drug house as properly. Fairly than simply reducing costs, they’re going to say, We provides you with a reduction, however you’re going to have to do that, that, and the opposite factor as a way to get it. 

Fortiér: Proper. However when you’re president and also you need credit score for it, it’s going to be a little bit extra — it’s more durable as a way to make that connection. Sorry. 

Rovner: Sure, that’s true. That could be a good level. All proper, transferring on. We’ve got talked lots about consolidation within the well being care trade, significantly corporations like UnitedHealthcare, which was simply an insurer, now owns its personal PBM [pharmacy benefit manager], its personal claims processing firm, and hundreds of medical practices across the nation. Properly, now a particularly unlikely pair within the Senate, Massachusetts Democrat Elizabeth Warren and Missouri Republican Josh Hawley, have joined to introduce one thing known as the Break Up Large Drugs Act, which might principally outlaw so-called vertical integration, like that of United and, to a considerably lesser extent, Cigna and CVS Well being, which owns Aetna, the insurer. Some are referring to this because the well being model of the 1932 Glass-Steagall Act, which separated business from funding banking — and, aspect notice, whose repeal in 1999 is taken into account a significant factor setting off the monetary disaster of 2008. However that was a danger factor. It was accomplished to stop one other inventory market crash just like the one in 1929. This can be a price factor. That is to go after excessive well being care prices. Might it work? Might it go? And is that this the start of the subsequent huge factor in well being reform? 

Lawrence: Maybe. Yeah. Final 12 months, I labored with my colleagues on a collection form of analyzing UnitedHealth Group and the results of consolidation on medical doctors and sufferers. And on the time, I believe, there have been some vocal lawmakers on both aspect of the aisle who had been criticizing this, particularly within the wake of the homicide of the UnitedHealth CEO, and which had a shocking — the general public type of had this response and to— 

Rovner: Not in United’s favor. 

Lawrence: Not in United’s favor. And so I believe that there is, it is a political concern that impacts everybody, Republican and Democrat, the, properly, price usually, however I believe there’s a variety of resentment and anger, and it looks like that’s bringing collectively these unlikely and fairly highly effective senators. I’m not an knowledgeable on the Hill. I don’t know if this has an opportunity. Particularly, it’s focusing on large, highly effective corporations with palms in each a part of the well being care system. So it’s one thing that you’d think about the complete well being care trade would battle towards. However, yeah, I don’t know. 

Rovner: And I’ll level out that Sen. Josh Hawley, along with all his anti-abortion actions, final 12 months, when Congress was debating the Medicaid cuts, stored vowing to not vote for these Medicaid cuts. So he’s — which, in fact, ultimately, he did — however he’s been type of on the patron aspect of well being take care of some time now. It’s simply this isn’t model new to him. 

Lawrence: Proper. And I’m unsure how many different Republican senators would comply with him down this path. However it’s positively a noteworthy growth, and curious to see the place it goes. 

Rovner: Yeah, I’m curious to see type of if the populist a part of well being care prices type of rises to the fore. We’ll should, we may have to look at that house. Properly, lastly this week, extra on the influence of the Trump administration’s immigration crackdowns and well being. My KFF Well being Information colleague Amy Maxmen has a narrative about well being professionals within the U.S. Public Well being Service Commissioned Corps really resigning moderately than accepting postings to Guantánamo Bay, Cuba, the place some immigrants are being detained in prisons that used to carry al-Qaida suspects. One other KFF Well being Information story by Claudia Boyd-Barrett describes how when folks detained by ICE [Immigration and Customs Enforcement] find yourself within the hospital, typically their instant households and their attorneys aren’t even allowed to know the place. And keep in mind, final week we talked about circumstances of measles in some immigration detention services. Properly, now there are two confirmed circumstances of tuberculosis on the ICE facility at Fort Bliss in El Paso, Texas. I’m considering possibly the well being a part of that is beginning to form of get to folks as a lot as the entire depriving-civil-liberties half. 

See also  Journalists Discuss Bird Flu, Tick-Borne Illnesses, and Lessons From Covid Response

Fortiér: Yeah, and there’s additionally been circumstances of covid-19, which is smart. You’re going to have respiratory viruses as you get a whole lot of individuals grouped collectively. That is smart. A choose in California a pair days in the past ordered that there needed to be ample well being supplied to detainees in a single particular California — it was a jail and now it’s an ICE detainee facility. That’s particular to there, nevertheless it’s — an increasing number of senators, I believe, are additionally this and mentioning that they’re simply not offering the well being services that individuals want. And particularly ongoing care — a lot of people want diabetes remedy, and that remedy simply isn’t actually occurring in many circumstances. 

Rovner: Yeah, we’ve talked about this at some size, over many weeks, that individuals in detention will not be getting well being care, though it is required, that we hold listening to tales about folks not getting wanted well being care. I didn’t know till I learn this story that individuals who really finish up being hospitalized, that their members of the family will not be allowed to know. That’s allegedly, properly, it’s due to safety, as a result of the thought is that if any individual who’s in detention is in a hospital, you don’t essentially need unhealthy folks understanding that and having the ability to come to the hospital. However these are folks typically who’re, as we’ve got documented at size, do not need felony information, and it’s exhausting to seek out out the place they’re. Alice, you needed so as to add one thing. 

Ollstein: Yeah. So there was a current GAO [Government Accountability Office] report about this, and it discovered that folks weren’t getting evaluated after they entered a facility to see in the event that they had been medically weak and vulnerable to having a extremely unhealthy episode or emergency, and that even kids, pregnant ladies, weak populations weren’t getting that preliminary analysis, which then led to issues down the highway. And it additionally stated that individuals upon their launch — both deportation or launch inside america if that’s what a courtroom ordered — they weren’t being given their medical information, their prescriptions. And so the continuity of care was disrupted. And it’s vital to notice that that GAO report was about a number of years in the past beneath the Biden administration. So this isn’t new. These issues aren’t new, however they’re getting a lot worse, as a result of the variety of folks detained is at document ranges and so the whole lot’s simply getting multiplied. 

Rovner: Yeah, it’s. Properly, we are going to hold watching that house. OK, that’s this week’s information. Earlier than we get to our further credit, I’m happy to current the winner of our annual KFF Well being Information Well being Coverage Valentine contest. It’s from [Andrew Carleen] of Massachusetts, primarily based on a narrative about Medicare Benefit overpayments. And it goes like this: “I assumed it was love. My coronary heart felt spring-loaded. Seems our relationship was considerably upcoded.” Congratulations, and comfortable Valentine’s Day to all. 

OK, now it’s time for our extra-credit phase. That’s the place we every acknowledge a story we learn this week we predict you need to learn, too. Don’t fear should you miss it. We’ll submit the hyperlinks in our present notes in your cellphone or different cell machine. Alice, why don’t you begin us off this week? 

Ollstein: Positive. So I’ve a form of enjoyable story [“Why Washington’s All-In on Smart Rings”] from my co-worker Amanda Chu about how the Oura ring has taken over D.C. They’ve been closely lobbying the Trump administration and Congress to stop robust rules. Principally, there’s a debate about whether or not it ought to be regulated as a medical machine or not. 

Rovner: Inform us once more what it does. 

Ollstein: It’s a hoop you put on in your finger that screens completely different well being metrics. And so the Trump administration MAHA motion has gone all in on this. They like it. The Pentagon has an enormous contract with them. Different authorities businesses are it, too. I believe it’s attention-grabbing as a result of it’s this very type of conservative mindset of particular person accountability in well being care and, oh, should you may simply monitor your individual metrics and do the fitting issues. That’s an method that’s type of counter to the thought of public well being and authorities defending your well being by way of coverage. 

Rovner: And we all know HHS Secretary Kennedy is a giant fan of wearables. 

Ollstein: Precisely, and this is without doubt one of the hottest ones proper now. And so this story does an excellent job digging into all of the lobbying and in addition into issues about knowledge privateness and mentioning that these applied sciences are transferring a lot sooner than authorities can regulate them. And that’s leaving some lawmakers actually involved about who may have entry to this knowledge. 

Rovner: Jackie. 

Fortiér: Mine is by Ariana Hendrix. She’s a author primarily based in Norway. It’s entitled “The New Childhood Vaccine Pointers Have a Paid Depart Drawback.” It was printed in Stat. And she or he writes eloquently about being a mum or dad in Norway and understanding that her kids wouldn’t go to day care till they had been about 16 months previous, as a result of Norway has paid parental depart. And she or he factors out, past the vaccine debate there’s an even bigger concern, that the U.S. lacks common well being care and federal paid parental depart. So modifications in toddler vaccines within the U.S. have a big impact, as a result of infants within the U.S. typically go to day care, when they’re round a variety of different youngsters when they’re simply a number of weeks previous. So she factors to the, in January, the toddler RSV [respiratory syncytial virus] vaccine was moved to the high-risk class of pictures, so now it isn’t routinely beneficial for all infants within the U.S. And RSV, in fact, is the commonest explanation for hospitalizations for infants, and that’s as a consequence of the truth that they’re uncovered to the virus in day care lots sooner than different kids in different international locations like Norway and Denmark whose vaccine schedules U.S. officers at the moment are form of attempting to emulate. So she does a extremely nice job of laying out how households face higher well being and monetary dangers within the U.S. with out the identical security internet that different international locations have. 

Rovner: Or simply the identical social insurance policies that different international locations have. 

Fortiér: Yeah, it reminded me— 

Rovner: It’s exhausting to, proper, it’s exhausting to import one other nation’s — a part of one other nation’s — insurance policies with out importing all of them. It’s actually good story. Lizzy. 

Lawrence: Yeah. So my piece is by Rachana Pradhan and KFF Well being Information, and it’s in regards to the “US Most cancers Institute Learning Ivermectin’s ‘Potential To Kill Most cancers Cells.’” And I assumed this piece was very attention-grabbing, simply because usually I’ve been fascinated by — politicization of medication isn’t new — however similar to right-wing-coded merchandise and left-wing-coded merchandise. And on this piece, Rachana talks about NIH [National Institutes of Health] Director Jay Bhattacharya form of speaking about how, It’s the folks’s NIH and if a variety of individuals are utilizing it, properly, we wish to examine it. So she simply, she does a extremely good job of form of unpacking why that is problematic, that they’re form of simply selecting a random medicine and there’s probably not any scientific purpose to be investing in it as a lot as they’re. And she or he received a response from NIH after the actual fact as properly, form of the place they had been attempting to defend this determination to pour this a lot funding. And so, yeah, I believe it’s simply a extremely attention-grabbing growth in NIH land. 

Rovner: It’s. My further credit score this week is from ProPublica, by Mica Rosenberg, and it’s known as “The Youngsters of Dilley.” It’s about what immigration detention seems like from the perspective of youngsters being held at a household facility in Dilley, Texas. That’s the one the place the 2 circumstances of measles had been identified earlier this winter. The story consists of some fairly wrenching letters and video calls from youngsters who had been residing elsewhere within the U.S., whereas their mother and father had been principally working throughout the immigration system. And these youngsters had been ripped from their each day lives, their different mother and father and siblings in some circumstances, their colleges and their classmates, and in many circumstances, from hope itself. Wrote one 14-year-old from Hicksville, New York, quote: “Since I received to this Heart all you’ll really feel is unhappiness and principally despair.” It actually is a must-read story. 

OK. That’s this week’s present. As all the time, due to our editor, Emmarie Huetteman, and our producer-engineer, Francis Ying. A reminder: What the Well being? is now out there on WAMU platforms, the NPR app, and wherever you get your podcasts, in addition to, in fact, kffhealthnews.org. Additionally, as all the time, you’ll be able to e mail us your feedback or questions. We’re at whatthehealth@kff.org. Or you will discover me on X, @jrovner, or on Bluesky, @julierovner. The place are you people hanging as of late? Jackie. 

Fortiér: Bluesky primarily, @jackie-fortier. 

Rovner: Alice. 

Ollstein: Primarily on Bluesky, @alicemiranda, and nonetheless on X, @AliceOllstein. 

Rovner: Lizzy. 

Lawrence: On X, @LizzyLaw_. On Bluesky, @lizzylawrence. 

Rovner: We’ll be again in your feed subsequent week. Till then, be wholesome. 

Credit

Francis Ying
Audio producer

Emmarie Huetteman
Editor

Click on right here to seek out all our podcasts.

And subscribe to “What the Well being? From KFF Well being Information” on Apple Podcasts, Spotify, the NPR app, YouTube, Pocket Casts, or wherever you take heed to podcasts.

Tags: FDAFluVax

Related Posts

Abortion Pill Politics – KFF Health News
Health Insurance

Abortion Pill Politics – KFF Health News

May 9, 2026
In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
Health Insurance

In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.

May 8, 2026
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
Health Insurance

Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.

May 7, 2026
A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
Health Insurance

A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know

May 6, 2026
Montana Moves Ahead With Doula Pay but Warns Medicaid Cuts Still May Come
Health Insurance

Montana Moves Ahead With Doula Pay but Warns Medicaid Cuts Still May Come

May 5, 2026
They’re in Remission, but Their Medical Bills Aren’t: Cancer Survivors Navigate Soaring Costs
Health Insurance

They’re in Remission, but Their Medical Bills Aren’t: Cancer Survivors Navigate Soaring Costs

May 4, 2026
Next Post
What Evidence Can Help Overturn a Denied Unum Disability Claim?

What Documents Do I Need to Support My New York Life Group LTD Claim?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR ARTICLES

How price shopping for health care can save you money (and how to do it)

How price shopping for health care can save you money (and how to do it)

August 1, 2022
Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings

Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings

August 1, 2022
Police Life Insurance [The Top 7 Job Risks that May Affect Your Rate!]

Police Life Insurance [The Top 7 Job Risks that May Affect Your Rate!]

March 31, 2023
Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life Care

Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life Care

August 1, 2022
Get Inflation Beating Retirement Income with Whole Life Insurance • The Insurance Pro Blog

Get Inflation Beating Retirement Income with Whole Life Insurance • The Insurance Pro Blog

October 6, 2022

EDITOR'S PICK

car insurance

Car Insurance Quotes

August 30, 2023
Navigating The Sea of Small Business Health and Dental Insurance Plans

Navigating The Sea of Small Business Health and Dental Insurance Plans

August 23, 2022
Finalized federal rule reduces total duration of short-term health plans to 4 months

Finalized federal rule reduces total duration of short-term health plans to 4 months

April 4, 2024
Ohio Governor Was Wrong to Veto Bill to Curb Transgenderism

Ohio Governor Was Wrong to Veto Bill to Curb Transgenderism

January 8, 2024

About

Insure Monkey is a free service to assist users in getting insurance quotes from insurance providers. Insure Monkey is not affiliated with any state or government agency. Insure Monkey is not an insurance agency or broker, nor an insurance referral service. Insure Monkey does not endorse or recommend any participating Third-Party Insurance Providers that pay to participate in this advertising.

Categories

  • Auto Insurance
  • Casualty Insurance
  • Health Care
  • Health Insurance
  • Insurance Education
  • Insurance for Business
  • Life Insurance
  • Medicare
  • Uncategorized

Recent Posts

  • On What Legal Grounds Can I Sue New York Life?
  • What 47 Years of Data Show
  • Abortion Pill Politics – KFF Health News

Newsletter

  • Insurance Quotes
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2024 Insure Monkey - All rights reserved.

No Result
View All Result
  • Home
  • Low Cost Health Insurance
  • News
    • Health Insurance
    • Insurance for Business
    • Health Care
    • Medicare
    • Casualty Insurance
    • Insurance Education
    • Life Insurance
  • Contact

© 2024 Insure Monkey - All rights reserved.